Maladaptive defensive behaviours in monoamine oxidase A-deficient mice

International Journal of Neuropsychopharmacology

Volumn 14, Issue 9, 2011, Pages 1195-1207

  Godar, Sean C ^a   Bortolato, Marco ^a   Frau, Roberto ^a,c   Dousti, Mona ^a   Chen, Kevin ^a   Shih, Jean C ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Anxiety; defensive behaviour; exploration; monoamine oxidase A; predator urine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING); ISOENZYME; MUTANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; DEFENSIVE BEHAVIOR; ESCAPE BEHAVIOR; FEAR; GENOTYPE; LOCOMOTION; MALADJUSTMENT; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; AGGRESSION; ANIMAL; ANIMAL BEHAVIOR; EXPLORATORY BEHAVIOR; GENETICS; LONG EVANS RAT; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY; POINT MUTATION; RANDOMIZATION; RAT;

AGGRESSION; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; ESCAPE REACTION; EXPLORATORY BEHAVIOR; ISOENZYMES; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MONOAMINE OXIDASE; MOTOR ACTIVITY; MUTANT PROTEINS; POINT MUTATION; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS;

EID: 84856074819     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001483     Document Type: Article

References (79)

1. Agatsuma S, Lee M, Zhu H, Chen K, et al. (2006). Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Human Molecular Genetics 15, 2721-2731. (Pubitemid 44400399)
2. Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, et al. (2008). Brain monoamine oxidase A activity predicts trait aggression. Journal of Neuroscience 28, 5099-5104.
3. Avgustinovich DF, Lipina TV, Bondar NP, Alekseyenko OV, et al. (2000). Features of the genetically defined anxiety in mice. Behavior Genetics 30, 101-109.
4. Belzung C, Le Pape G (1994). Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiology & Behavior 56, 623-628. (Pubitemid 24269590)
5. Blair RJR (2009). The neurobiology of aggression. In : Charney DS, Nestler EJ (Eds), Neurobiology of Mental Illness (pp. 1307-1320). Oxford: Oxford University Press.
6. Blanchard D, Blanchard RJ (2008). Defensive behaviors, fear, and anxiety. In : Blanchard R, Blanchard DC, Griebel G, Nutt DJ (Eds), Handbook of Anxiety and Fear (pp. 63-79). Amsterdam: Academic Press.
7. Bolte S, Poustka F (2003). The recognition of facial affect in autistic and schizophrenic subjects and their first-degree relatives. Psychological Medicine 33, 907-915. (Pubitemid 36874670)
8. Bondi CO, Barrera G, Lapiz MD, Bedard T, et al. (2007). Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Progress in Neuropsychopharmacology & Biological Psychiatry 31, 482-495. (Pubitemid 46209446)
9. Bortolato M, Godar SC, Davarian S, Chen K, et al. (2009). Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34, 2746-2757.
10. Brecht M, Preilowski B, Merzenich MM (1997). Functional architecture of the mystacial vibrissae. Behavioural Brain Research 84, 81-97. (Pubitemid 27112687)
11. Brummett BH, Boyle SH, Siegler IC, Kuhn CM, et al. (2008). HPA axis function in male caregivers : effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR). Biological Psychology 79, 250-255.
12. Brunner HG, Nelen M, Breakefield XO, Ropers HH, et al. (1993a). Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580. (Pubitemid 23350673)
13. Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, et al. (1993b). X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. American Journal of Human Genetics 52, 1032-1039. (Pubitemid 23311342)
14. Buckholtz JW, Meyer-Lindenberg A (2008). MAOA and the neurogenetic architecture of human aggression. Trends in Neuroscience 31, 120-129.
15. Camarena B, Rinetti G, Cruz C, Gomez A, et al. (2001). Additional evidence that genetic variation of MAO A gene supports a gender subtype in obsessive-compulsive disorder. American Journal of Medical Genetics 105, 279-282. (Pubitemid 32410903)
16. Campbell T, Lin S, DeVries C, Lambert K (2003). Coping strategies in male and female rats exposed to multiple stressors. Physiology & Behavior 78, 495-504. (Pubitemid 36369722)
17. Carvalho-Netto EF, Nunes-de-Souza RL (2004). Use of the elevated T-maze to study anxiety in mice. Behavioural Brain Research 148, 119-132. (Pubitemid 37543661)
18. Cases O, Seif I, Grimsby J, Gaspar P, et al. (1995). Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766.
19. Cases O, Vitalis T, Seif I, De Maeyer E, et al. (1996). Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16, 297-307.
20. Caspi A, McClay J, Moffitt TE, Mill J, et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854. (Pubitemid 34839638)
21. Chugani DC (2002). Role of altered brain serotonin mechanisms in autism. Molecular Psychiatry 7 (Suppl. 2), S16-17.
22. Cohen IL, Liu X, Lewis ME, Chudley A, et al. (in press). Autism severity is associated with child and maternal MAOA genotypes. Clinical Genetics.
23. Cohen IL, Liu X, Schutz C, White BN, et al. (2003). Association of autism severity with a monoamine oxidase A functional polymorphism. Clinical Genetics 64, 190-197. (Pubitemid 37069450)
24. Davis LK, Hazlett HC, Librant AL, Nopoulos P, et al. (2008). Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B, 1145-1151.
25. Dawson G, Webb SJ, Carver L, Panagiotides H, et al. (2004). Young children with autism show atypical brain responses to fearful vs. neutral facial expressions of emotion. Developmental Science 7, 340-359. (Pubitemid 38750669)
26. Dowman R, Ben-Avraham D (2008). An artificial neural network model of orienting attention toward threatening somatosensory stimuli. Psychophysiology 45, 229-239. (Pubitemid 351197137)
27. Dringenberg HC, Dennis KE, Tomaszek S, Martin J (2003). Orienting and defensive behaviors elicited by superior colliculus stimulation in rats : effects of 5-HT depletion, uptake inhibition, and direct midbrain or frontal cortex application. Behavioural Brain Research 144, 95-103. (Pubitemid 37011170)
28. Erzurumlu RS, Jhaveri S (1990). Thalamic axons confer a blueprint of the sensory periphery onto the developing rat somatosensory cortex. Brain Research. Developmental Brain Research 56, 229-234. (Pubitemid 20364133)
29. Foley DL, Eaves LJ, Wormley B, Silberg JL, et al. (2004). Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Archives of General Psychiatry 61, 738-744. (Pubitemid 38890809)
30. Fox MW (1965). The visual cliff test for the study of visual depth perception in the mouse. Animal Behaviour 13, 232-233.
31. Graeff FG (1993). Role of 5-HT in defensive behavior and anxiety. Reviews in the Neurosciences 4, 181-211. (Pubitemid 23223670)
32. Grahn RE, Hammack SE, Will MJ, O'Connor KA, et al. (2002). Blockade of alpha1 adrenoreceptors in the dorsal raphe nucleus prevents enhanced conditioned fear and impaired escape performance following uncontrollable stressor exposure in rats. Behavioural Brain Research 134, 387-392. (Pubitemid 34912717)
33. Green MJ, Waldron JH, Coltheart M (2007). Emotional context processing is impaired in schizophrenia. Cognitive Neuropsychiatry 12, 259-280. (Pubitemid 46598193)
34. Griebel G, Curet O, Perrault G, Sanger DJ (1998). Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology 37, 927-935. (Pubitemid 28375759)
35. Gur RE, Loughead J, Kohler CG, Elliott MA, et al. (2007). Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Archives of General Psychiatry 64, 1356-1366. (Pubitemid 350223553)
36. Hall J, Whalley HC, McKirdy JW, Romaniuk L, et al. (2008). Overactivation of fear systems to neutral faces in schizophrenia. Biological Psychiatry 64, 70-73.
37. Hare TA, Tottenham N, Galvan A, Voss HU, et al. (2008). Biological substrates of emotional reactivity and regulation in adolescence during an emotional go-nogo task. Biological Psychiatry 63, 927-934. (Pubitemid 351602274)
38. Hebebrand J, Klug B (1995). Specification of the phenotype required for men with monoamine oxidase type A deficiency. Human Genetics 96, 372-376.
39. Holmes A, Yang RJ, Lesch KP, Crawley JN, et al. (2003). Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28, 2077-2088. (Pubitemid 37468176)
40. Hurwitz BE, Dietrich WD, McCabe PM, Watson BD, et al. (1990). Sensory-motor deficit and recovery from thrombotic infarction of the vibrissal barrel-field cortex. Brain Research 512, 210-220. (Pubitemid 20107461)
41. Ibanez A, Perez de Castro I, Fernandez-Piqueras J, Blanco C, et al. (2000). Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Molecular Psychiatry 5, 105-109. (Pubitemid 30088461)
42. Jabbi M, Korf J, Kema IP, Hartman C, et al. (2007). Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Molecular Psychiatry 12, 483-490. (Pubitemid 46652463)
43. Jacob CP, Muller J, Schmidt M, Hohenberger K, et al. (2005). Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology 30, 1711-1718. (Pubitemid 43086028)
44. Kim JJ, Shih JC, Chen K, Chen L, et al. (1997). Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proceedings of the National Academy of Sciences USA 94, 5929-5933. (Pubitemid 27241874)
45. Kumari V, Barkataki I, Goswami S, Flora S, et al. (2009). Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia. Psychiatry Research 173, 39-44.
46. Lee BT, Ham BJ (2008). Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 19, 515-519.
47. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, et al. (2007). Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology 32, 1531-1539.
48. Luhmann HJ, Huston JP, Hasenohrl RU (2005). Contralateral increase in thigmotactic scanning following unilateral barrel-cortex lesion in mice. Behavioural Brain Research 157, 39-43. (Pubitemid 40029697)
49. Marques JM, Olsson IA, Ogren SO, Dahlborn K (2008). Evaluation of exploration and risk assessment in pre-weaning mice using the novel cage test. Physiology & Behavior 93, 139-147.
50. Mejia JM, Ervin FR, Baker GB, Palmour RM (2002). Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice. Biological Psychiatry 52, 811-821.
51. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri A, et al. (2006). Neural mechanisms of genetic risk for impulsivity and violence in humans. Proceedings of the National Academy of Sciences USA 103, 6269-6274.
52. Morris RW, Weickert CS, Loughland CM (2009). Emotional face processing in schizophrenia. Current Opinion in Psychiatry 22, 140-146.
53. Nilsson KW, Sjoberg RL, Damberg M, Leppert J, et al. (2006). Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biological Psychiatry 59, 121-127. (Pubitemid 43117501)
54. Paulus MP, Dulawa SC, Ralph RJ, Mark AG (1999). Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Research 835, 27-36. (Pubitemid 29336547)
55. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J (2002). Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO A and the 5-HT transporter genes. Molecular Psychiatry 7, 927-928. (Pubitemid 35333044)
56. Phillips ML, Williams L, Senior C, Bullmore ET, et al. (1999). A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Research 92, 11-31. (Pubitemid 29512390)
57. Popova NK, Maslova LN, Morosova EA, Bulygina VV, et al. (2006). MAO A knockout attenuates adrenocortical response to various kinds of stress. Psychoneuroendocrinology 31, 179-186. (Pubitemid 41740439)
58. Popova NK, Skrinskaya YA, Amstislavskaya TG, Vishnivetskaya GB, et al. (2001). Behavioral characteristics of mice with genetic knockout of monoamine oxidase type A. Neuroscience and Behavioral Physiology 31, 597-602. (Pubitemid 34007366)
59. Rodgers RJ, Cole JC, Cobain MR, Daly P, et al. (1992). Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behavioural Pharmacology 3, 621-634. (Pubitemid 23009881)
60. Rodgers RJ, Johnson NJ (1995). Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology, Biochemistry, and Behavior 52, 297-303.
61. Salichon N, Gaspar P, Upton AL, Picaud S, et al. (2001). Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. Journal of Neuroscience 21, 884-896. (Pubitemid 32163130)
62. Sanders MJ, Dietrich WD, Green EJ (2001). Behavioral, electrophysiological, and histopathological consequences of mild fluid-percussion injury in the rat. Brain Research 904, 141-144. (Pubitemid 32545363)
63. Scott AL, Bortolato M, Chen K, Shih JC (2008). Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 19, 739-743. (Pubitemid 351555982)
64. Seiferth NY, Pauly K, Habel U, Kellermann T, et al. (2008). Increased neural response related to neutral faces in individuals at risk for psychosis. Neuroimage 40, 289-297.
65. Shih JC, Ridd MJ, Chen K, Meehan WP, et al. (1999). Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A. Brain Research 835, 104-112. (Pubitemid 29343772)
66. Shiraishi H, Suzuki A, Fukasawa T, Aoshima T, et al. (2006). Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants. Psychiatric Genetics 16, 55-58. (Pubitemid 44481205)
67. Steckler T, Rammes G, Sauvage M, van Gaalen MM, et al. (2001). Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. Journal of Psychiatric Research 35, 29-42. (Pubitemid 32233168)
68. Straube T, Schmidt S, Weiss T, Mentzel HJ, et al. (2009). Dynamic activation of the anterior cingulate cortex during anticipatory anxiety. Neuroimage 44, 975-981.
69. Surguladze S, Russell T, Kucharska-Pietura K, Travis MJ, et al. (2006). A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biological Psychiatry 60, 423-431. (Pubitemid 44292157)
70. Torrejais JC, Rosa CC, Boerngen-Lacerda R, Andreatini R (2008). The elevated T-maze as a measure of two types of defensive reactions : a factor analysis. Brain Research Bulletin 76, 376-379.
71. Upton AL, Salichon N, Lebrand C, Ravary A, et al. (1999). Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. Journal of Neuroscience 19, 7007-7024. (Pubitemid 29380127)
72. Van't Wout M, van Dijke A, Aleman A, Kessels RP, et al. (2007). Fearful faces in schizophrenia : the relationship between patient characteristics and facial affect recognition. Journal of Nervous and Mental Disease 195, 758-764. (Pubitemid 351627641)
73. Viana MB, Tomaz C, Graeff FG (1994). The elevated T-maze: a new animal model of anxiety and memory. Pharmacology, Biochemistry, and Behavior 49, 549-554. (Pubitemid 24335634)
74. Vishnivetskaya GB, Skrinskaya JA, Seif I, Popova NK (2007). Effect of MAO A deficiency on different kinds of aggression and social investigation in mice. Aggressive Behavior 33, 1-6.
75. Vitalis T, Cases O, Callebert J, Launay JM, et al. (1998). Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex : determination of a sensitive developmental period. Journal of Comparative Neurology 393, 169-184. (Pubitemid 28141643)
76. Whitaker-Azmitia PM, Zhang X, Clarke C (1994). Effects of gestational exposure to monoamine oxidase inhibitors in rats : preliminary behavioral and neurochemical studies. Neuropsychopharmacology 11, 125-132. (Pubitemid 24334068)
77. Williams LM, Gatt JM, Kuan SA, Dobson-Stone C, et al. (2009). A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index. Neuropsychopharmacology 34, 1797-1809.
78. Yang M, Crawley JN (2009). Simple behavioral assessment of mouse olfaction. Current Protocols in Neuroscience, Chapter 8 : Unit 8 24.
79. Yoo HJ, Lee SK, Park M, Cho IH, et al. (2009). Family-and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neuroscience Research 63, 172-176.